Keryx Biopharmaceuticals Inc, KERX Securities Lawsuit

- by

Company: Keryx Biopharmaceuticals Inc,
Ticker Symbol: KERX
Class Period: Jun-1-09 to Apr-1-12
Date Filed: Feb-1-13
Lead Plaintiff Deadline: Apr-2-13
Court: Southern District of New York
Oklahoma City, OK: A securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Keryx Biopharmaceuticals Inc, (NASDAQ: KERX).

The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is June 1, 2009 through April 1, 2012.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Keryx Biopharmaceuticals Inc, KERX Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Keryx Biopharmaceuticals Inc, securities class action lawsuit. Please fill in our form on the right to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help